The SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the SCN1A gene, which have been associated with Familial Hemiplegic Migraine Type 3 (FHM3). Familial Hemiplegic Migraine is a rare subtype of migraine with aura, characterized by temporary paralysis on one side of the body, visual disturbances, and sometimes speech difficulties before the onset of headache. The SCN1A gene plays a crucial role in the functioning of nerve cells in the brain, and mutations in this gene can disrupt ion channels, leading to the symptoms of FHM3.

This genetic test is crucial for individuals with a family history of FHM3, as it can provide definitive confirmation of the mutation presence, aiding in the accurate diagnosis and management of the condition. The test involves a simple blood draw or cheek swab, with the sample then analyzed for specific genetic mutations in the SCN1A gene.

The cost of the SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its importance in the precise diagnosis and potential treatment strategies for individuals with or at risk of FHM3, the investment can be invaluable for affected families seeking clarity on their genetic status and how it may impact their health management plans.